NasdaqCM - Delayed Quote • USD
Aspira Women's Health Inc. (AWH)
At close: April 25 at 4:00 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,177.0000
8,184.0000
6,812.0000
4,651.0000
Cost of Revenue
3,898.0000
3,861.0000
3,750.0000
3,415.0000
Gross Profit
5,279.0000
4,323.0000
3,062.0000
1,236.0000
Operating Expense
26,714.0000
35,461.0000
35,657.0000
19,217.0000
Operating Income
-21,435.0000
-31,138.0000
-32,595.0000
-17,981.0000
Net Non Operating Interest Income Expense
73.0000
17.0000
-48.0000
10.0000
Other Income Expense
5,885.0000
1,236.0000
981.0000
66.0000
Pretax Income
-15,477.0000
-29,885.0000
-31,662.0000
-17,905.0000
Net Income Common Stockholders
-15,477.0000
-29,885.0000
-31,662.0000
-17,905.0000
Diluted NI Available to Com Stockholders
-15,477.0000
-29,885.0000
-31,662.0000
-17,905.0000
Basic EPS
-1.66
-866.25
-960.75
-2.70
Diluted EPS
-1.66
-866.25
-960.75
-2.70
Basic Average Shares
7,769.1080
34.5290
32.9510
6,714.8860
Diluted Average Shares
7,769.1080
34.5290
32.9510
6,714.8860
Total Operating Income as Reported
-21,435.0000
-31,138.0000
-32,595.0000
-17,981.0000
Total Expenses
30,612.0000
39,322.0000
39,407.0000
22,632.0000
Net Income from Continuing & Discontinued Operation
-15,477.0000
-29,885.0000
-31,662.0000
-17,905.0000
Normalized Income
-19,480.0000
-31,589.0000
-31,662.0000
-17,905.0000
Interest Income
--
--
--
10.0000
Net Interest Income
73.0000
17.0000
-48.0000
10.0000
EBIT
-22,198.0000
-31,138.0000
-32,595.0000
-17,981.0000
EBITDA
-21,967.0000
-30,874.0000
-32,293.0000
-17,716.0000
Reconciled Cost of Revenue
3,898.0000
3,861.0000
3,750.0000
3,415.0000
Reconciled Depreciation
231.0000
264.0000
302.0000
265.0000
Net Income from Continuing Operation Net Minority Interest
-15,477.0000
-29,885.0000
-31,662.0000
-17,905.0000
Total Unusual Items Excluding Goodwill
4,003.0000
1,704.0000
--
--
Total Unusual Items
4,003.0000
1,704.0000
--
--
Normalized EBITDA
-25,970.0000
-32,578.0000
-32,293.0000
-17,716.0000
12/31/2020 - 10/2/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDSX Biodesix, Inc.
1.2600
0.00%
CORBF Global Cord Blood Corporation
1.2500
-7.41%
XGN Exagen Inc.
1.4100
+2.92%
PMD Psychemedics Corporation
2.5400
-5.22%
FONR FONAR Corporation
16.86
+4.14%
ENZ Enzo Biochem, Inc.
1.0700
+0.94%
NDRA ENDRA Life Sciences Inc.
0.2425
-6.69%
PRE Prenetics Global Limited
4.9700
+3.76%
ACRS Aclaris Therapeutics, Inc.
1.1900
+1.71%
DRIO DarioHealth Corp.
1.4700
-2.00%